BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31567202)

  • 21. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.
    Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF
    World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathologic Prognostic Factors of Pineal Parenchymal Tumor of Intermediate Differentiation.
    Chatterjee D; Lath K; Singla N; Kumar N; Radotra BD
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):210-215. PubMed ID: 28800009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological study of pineal parenchymal tumors: correlation between histopathological features, proliferative potential, and prognosis.
    Tsumanuma I; Tanaka R; Washiyama K
    Brain Tumor Pathol; 1999; 16(2):61-8. PubMed ID: 10746962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathological and immunohistochemical study of pineal parenchymal tumors].
    Fang J; Luo L; Li J; Sun S; Yuan Y
    Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):8-11. PubMed ID: 11955327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
    Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
    Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extent of Resection and Long-Term Survival of Pineal Region Tumors in Helsinki Neurosurgery.
    Choque-Velasquez J; Resendiz-Nieves J; Jahromi BR; Colasanti R; Raj R; Vehviläinen J; Tynninen O; Collan J; Niemelä M; Hernesniemi J
    World Neurosurg; 2019 Nov; 131():e379-e391. PubMed ID: 31369883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and ultrastructural characteristics of human pineal gland, and pineal parenchymal tumors.
    Jouvet A; Fèvre-Montange M; Besançon R; Derrington E; Saint-Pierre G; Belin MF; Pialat J; Lapras C
    Acta Neuropathol; 1994; 88(4):334-48. PubMed ID: 7839826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis.
    Mallick S; Benson R; Rath GK
    Radiother Oncol; 2016 Nov; 121(2):204-208. PubMed ID: 27865543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative genomic hybridization in pineal parenchymal tumors.
    Rickert CH; Simon R; Bergmann M; Dockhorn-Dworniczak B; Paulus W
    Genes Chromosomes Cancer; 2001 Jan; 30(1):99-104. PubMed ID: 11107183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors.
    Fukuda T; Akiyama N; Ikegami M; Takahashi H; Sasaki A; Oka H; Komori T; Tanaka Y; Nakazato Y; Akimoto J; Tanaka M; Okada Y; Saito S
    J Neuropathol Exp Neurol; 2010 May; 69(5):498-510. PubMed ID: 20418777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
    Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
    Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical characterization of pineal parenchymal tumors using novel monoclonal antibodies to the pineal body.
    Yamane Y; Mena H; Nakazato Y
    Neuropathology; 2002 Jun; 22(2):66-76. PubMed ID: 12075938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pineal parenchymal tumor of intermediate differentiation with cytologic pleomorphism.
    Sasaki A; Horiguchi K; Nakazato Y
    Neuropathology; 2006 Jun; 26(3):212-7. PubMed ID: 16771177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological analysis of lesions of the pineal region: a retrospective study of 12 years.
    Kumar P; Tatke M; Sharma A; Singh D
    Pathol Res Pract; 2006; 202(2):85-92. PubMed ID: 16413691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
    Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
    Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pineal Parenchymal Tumors of Intermediate Differentiation: A Case Report and Literature Review.
    Samkari AM; Alshehri FD; AlMehdar AS; Matar MY
    Cureus; 2023 Dec; 15(12):e50139. PubMed ID: 38192964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
    Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S;
    J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histology-Stratified Tumor Control and Patient Survival After Stereotactic Radiosurgery for Pineal Region Tumors: A Report From the International Gamma Knife Research Foundation.
    Iorio-Morin C; Kano H; Huang M; Lunsford LD; Simonová G; Liscak R; Cohen-Inbar O; Sheehan J; Lee CC; Wu HM; Mathieu D
    World Neurosurg; 2017 Nov; 107():974-982. PubMed ID: 28751141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of neuroendoscopic procedures in minimally invasive preferential management of pineal region tumors: a prospective study.
    Oi S; Shibata M; Tominaga J; Honda Y; Shinoda M; Takei F; Tsugane R; Matsuzawa K; Sato O
    J Neurosurg; 2000 Aug; 93(2):245-53. PubMed ID: 10930010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rosette-Forming Glioneuronal Tumor in the Pineal Region: A Series of 6 Cases and Literature Review.
    Lin CC; Mansukhani MM; Bruce JN; Canoll P; Zanazzi G
    J Neuropathol Exp Neurol; 2021 Oct; 80(10):933-943. PubMed ID: 34498065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.